Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
20,171
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Daiichi Sankyo Co., Ltd. - ADR market cap is $31.76B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Daiichi Sankyo Co., Ltd. - ADR 52 week high is $24.77 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Daiichi Sankyo Co., Ltd. - ADR 52 week low is $14.98 as of November 18, 2026.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Daiichi Sankyo Co., Ltd. - ADR's P/E ratio is 16.73.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Daiichi Sankyo Co., Ltd. - ADR P/B ratio is 2.8392.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Daiichi Sankyo Co., Ltd. - ADR 50-day moving average is $17.76.
Daiichi Sankyo Co., Ltd. - ADR has 20,171 employees.